TRIO-US, Inc.
Meghan Brennan is the Chief Operating Officer at TRIO-US, Inc., where she oversees a national site management organization focused on translational oncology clinical research. She previously held positions at City of Hope and UCLA Health, where she managed clinical research operations and execution of clinical trials for adult and pediatric oncology. Meghan holds a Ph.D. in Nursing from UCLA, a Master's Degree in Nurse Practitioner, and a BSN from Georgetown University.
This person is not in any teams
TRIO-US, Inc.
Translational Research In Oncology-US, Inc. (TRIO-US) is a site management organization (SMO) made up of a committed group of community oncologists interested in participating in translational research studies. The TRIO-US Network consists of more than 15 community oncology practices across multiple states, a majority in Southern California. TRIO-US is affiliated with the UCLA Jonsson Comprehensive Cancer Center (JCCC) to bring cutting edge clinical research trials to our sites. Many of the TRIO-US Network sites have participated in clinical trials with since the inception of the network over 20 years ago.